MB

Mhd Bassam Naassan

Director Director DIN 03089839
DIN 03089839 First appointment Jun 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Jun 2010
Shareholding value •••• Premium profile

About Mhd Bassam Naassan

Data last updated:

Mhd Bassam Naassan was a Director at Cooper Pharma Limited (2012–2019) and Director at Surya Sweets Private Limited (2010–2011). The companies operate in Pharma and Food And Beverages.

DIN 03089839
Primary Designation Director
Industry Pharma
First Appointment 01 Jun 2010

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cooper Pharma Limited U24231DL1989PLC034902
Director30 Aug 20121989₹63.28 Cr (FY 2024)Active
Surya Sweets Private Limited U15490DL2010PTC203414
Director01 Jun 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Cooper Pharma Limited
Surya Sweets Private Limited
Premium access

Shareholding and investment profile for Mhd Bassam Naassan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mhd Bassam Naassan

Mhd Bassam Naassan was first appointed on 01 Jun 2010 as Director at Surya Sweets Private Limited. The most recent appointment on record is 30 Aug 2012 at Cooper Pharma Limited.

Mhd Bassam Naassan held 2 earlier board appointments: Cooper Pharma Limited (Director, 30 Aug 2012 to 21 May 2019); Surya Sweets Private Limited (Director, 01 Jun 2010 to 09 Jun 2011).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available